Chinese scientists have found a revolutionary way to prolong the lives of cancer patients.

Chinese scientists announced the discovery of a new immunotherapy method that increases the lifespan of cancer patients. CAR-T studies showed that patients with stomach and esophageal cancer who underwent this treatment lived an average of 40% longer than those who used older methods. Moreover, the effectiveness of this method may be beneficial in treating solid tumors, not just in fighting blood cancer.

Those who received CAR-T therapy had an average of 7.9 months of living time, compared to 5.5 months with standard treatment. Additionally, they also had a longer-lasting remission compared to those who received traditional treatment.

This immunotherapy method has proven effective in combating various types of cancer, including glioblastoma - an aggressive brain tumor. The results of the study indicate significant potential and opportunities for this method in treating oncological diseases.

This news asserts that CAR-T immunotherapy may be a promising method in combating different types of cancer, helping patients to live longer and improve their quality of life. The discovery by Chinese scientists could have great significance for patients not only in China but also around the world, opening new possibilities in the treatment of oncological diseases.